Banning mRNA technology in response to the many missteps of public health officials during the pandemic is a textbook example ...

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

Pfizer has now announced that ... and 100 times The People’s Vaccine Alliance’s estimated cost of manufacture of each vial. This estimation was drawn from an analysis of data from consumer ...

FILE - A vial of the Phase 3 Novavax coronavirus ... It is still being sold under emergency use authorization — unlike mRNA vaccines made by Pfizer and Moderna that have earned full FDA approval ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device industries. He has written about Covid-19 vaccines, advances in cancer treatments, ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

When it comes to getting the most out of a vaccine, arm consistency can make a difference. Some studies suggest that getting ...

The vaccine is the only protein-based COVID shot still in use in the U.S. This approval would allow the vaccine to stay on ...

Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...

Novavax has been available since 2022 through a pandemic-era Emergency Use Authorization. A decision on full approval – which ...